Healthcare | December 11, 2024
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
The MoU signed in 2022 has progressed and culminated in the subsumption of FOGSI-led Manyata initiative’s 20 quality standards across NABH’s Certification programs
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Infant Mortality Rate in Bihar came down from 42 to 27 in 2020, and in Jharkhand, from 34 to 25 in 2020
Subscribe To Our Newsletter & Stay Updated
